Ackman Love Letter To Allergan This Morning Shows Desire
Earlier this morning, Bill Ackman sent a love letter to the Allergan board of directors to which Allergan, Inc. (NYSE:AGN) has responded, as exclusively reported in ValueWalk.
“We have read your recent SEC filings and published reports which state that you are negotiating a potential merger transaction with a third party, widely reported to be Actavis plc (NYSE:ACT),” the
SORRY! This content is exclusively for paying members. If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.